PSMD1 and infection: Strengths of our study include a prospective, highly characterized, multi-ethnic, US general population-based sample that has comprehensive pre-pandemic phenotyping; semi-quantitative assessment of anti-S1 IgG responses using validated methods; an integrated definition of prior infection using self-report, hospital records, and anti-N antibody response; and extended follow-up after vaccination.